📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
85
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📜 Warrant Exercise
15%
• Warrant overhang: 11.6% of shares outstanding
💹 Market Data
Market Cap$447.83M
Shares Outstanding15.80M
Float6.01M
Cash$243.18M
Debt$9.13M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 7.9% shares (2025Q4 vs prior)
95 institutional holders · 16.61M shares
#1
SAMSARA BIOCAPITAL, LLC
1.72M shares
#2
Redmile Group, LLC
1.46M shares
#3
RTW INVESTMENTS, LP
1.36M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.60M
Days to Cover24.6
% of Float60.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
xbrl
XBRL WARRANT
Dec 18, 2023
4
INSIDER TRANSACTION
Mar 30, 2026
4
INSIDER TRANSACTION
Mar 30, 2026
4
INSIDER TRANSACTION
Mar 30, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NGNE
📊 NGNE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NGNE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.